Proinflammatory cytokines are critically involved in the alteration of adipose tissue biology
leading to deterioration of glucose homeostasis in obesity. Here we show a pronounced …

Inflammatory mediators have the potential to impact a surprising range of diseases,
including obesity and its associated metabolic syndrome. In this paper, we show that the …

The pro-inflammatory cytokine interleukin (IL)-17 (also known as IL-17) has been associated
with induction of tissue inflammation. Obese individuals exhibit many symptoms of chronic …

IL-17 is an inflammatory cytokine associated with anti-microbial host defense and
pathogenesis of autoimmune diseases. Obesity is considered to be an inflammatory …

An alarming global rise in the prevalence of obesity and its contribution to the development
of chronic diseases is a serious health concern. Recently, obesity has been described as a …

Introduction The proinflammatory cytokine IL‐18 is involved in the pathogenesis of metabolic
syndrome. While the changes in IL‐18 are known, IL‐18R expression and relationship with …

The immune system is closely linked to human metabolic diseases. Serum levels of IL-6
increase with obesity and insulin resistance. Not only does IL-6 decrease the insulin …

Obesity is associated with low-grade chronic inflammation. Indeed, adipose tissues (AT) in
obese individuals are the former site of progressive infiltration by pro-inflammatory immune …

The prevalence of metabolic diseases associated with obesity, such as type 2 diabetes,
continues to rise along with obesity rates. Recently, obesity has been described as an …

In obesity, chronic inflammation is believed to induce insulin resistance and impairs adipose
tissue function. Although this view is supported by a large body of literature, it has been …